Dr. Lahlou discusses the complex role of adipose tissue, explaining its function as an endocrine organ that plays a significant role in metabolism, immunity, and inflammation. She emphasizes that obesity is not merely a cosmetic issue but a serious health condition that can lead to various diseases, including diabetes, hypertension, and cancer.
The conversation also delves into the use of GLP-1 agonists and bariatric surgery as treatments for obesity. Dr. Lahlou explains that GLP-1 agonists, initially developed for diabetes treatment, are now being used to treat obesity because they help reduce food cravings and manage metabolic disorders. However, she also highlights the challenges, including side effects and the high cost of these medications.
Dr. Lahlou also touches on the importance of screening for underlying conditions like ADHD, which can complicate weight management due to issues with impulse control and emotional regulation. She explains that ADHD, often underdiagnosed in obese patients, can contribute to food addiction and challenges in following structured weight loss plans.
The episode concludes with Dr. Lahlou's thoughts on the future of obesity medicine, her focus on educating medical students and residents, and her hope for a more compassionate approach to treating obesity, recognizing it as a complex, multifaceted condition rather than a simple issue of willpower or discipline.
Follow Dr. Lahlou:
The content of our show is educational only. It does not supplement or supersede your healthcare provider's professional relationship and direction. Always seek the advice of your physician or other qualified mental health providers with any questions you may have regarding a medical condition, substance use disorder, or mental health concern.